Zobrazeno 1 - 10
of 232
pro vyhledávání: '"Ziv-aflibercept"'
Publikováno v:
International Journal of Retina and Vitreous, Vol 10, Iss 1, Pp 1-8 (2024)
Abstract Background Previous studies have shown promising effects of combining intravitreal bevacizumab and suprachoroidal injection of triamcinolone acetonide in treating DME. However, further research is needed. Objective To assess the efficacy and
Externí odkaz:
https://doaj.org/article/9f9bd4d9465048609ed553d03df0cd32
Publikováno v:
Clinical Ophthalmology, Vol Volume 17, Pp 2719-2728 (2023)
Suthasinee Sinawat,1,2 Suthasinee Hemanak,1 Kwanchanok Chanthowong,1 Supat Sinawat,3 Yosanan Yospaiboon1,2 1Department of Ophthalmology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand; 2KKU Eye Center, Khon Kaen University, Khon Kaen,
Externí odkaz:
https://doaj.org/article/e3de5b1f627a46b8957f6a02dca807a7
Autor:
Siamak Moradian, Masoud Soheilian, Mahsan Asadi, Abdolreza Baghi, Hamid Safi, Seyed-Hossein Abtahi
Publikováno v:
Journal of Ophthalmic & Vision Research, Vol 18, Iss 2, Pp 164-169 (2023)
Abstract Purpose: To evaluate the effects of intravitreal ziv-aflibercept injections (IVZ) on subfoveal choroidal thickness (SCT) as well as on central macular thickness (CMT) and on best corrected visual acuity (BCVA) changes in eyes with center-inv
Externí odkaz:
https://doaj.org/article/91634bc6c72a4767b942c99560555a28
Autor:
Munayco-Guillén F, Vazquez-Membrillo MA, Garcia-Roa MR, De La Cruz-Vargas JA, García-Perdomo HA, Pichardo-Rodriguez R
Publikováno v:
Clinical Ophthalmology, Vol Volume 17, Pp 1129-1135 (2023)
Fernando Munayco-Guillén,1,2 Miguel Angel Vazquez-Membrillo,1,2 Marlon Rafael Garcia-Roa,1,2 Jhony Alberto De La Cruz-Vargas,3 Herney Andrés García-Perdomo,4 Rafael Pichardo-Rodriguez3 1Department of Retina and Vitreous Surgery, Instituto Mexicano
Externí odkaz:
https://doaj.org/article/4d89db697b374abfaa7aed3584ffa28b
Publikováno v:
BMC Ophthalmology, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Diabetic macular edema (DME) is a leading cause of visual loss in diabetic patients and is managed using multiple anti-vascular endothelial growth factor (VEGF) agents such as bevacizumab, ranibizumab and aflibercept. The present
Externí odkaz:
https://doaj.org/article/ddaf94ca402b447ea207b4f40b730bbd
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Amin E. Nawar, Heba M. Shafik
Publikováno v:
BMC Ophthalmology, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background Myopic choroidal neovascularization (CNV) is the most common sight-threatening complication associated with high myopia. The present study evaluated the efficacy and safety of the intravitreal injection of ziv-aflibercept in patie
Externí odkaz:
https://doaj.org/article/9325afd5ea7b4439b93ec0654c3a2a67
Autor:
Sumit Randhir Singh, Ravi Parikh, Yoichi Sakurada, Bhushan Uplanchiwar, Ahmad Mansour, Abhilash Goud, Yasha S Modi, Jay Chhablani
Publikováno v:
Taiwan Journal of Ophthalmology, Vol 10, Iss 4, Pp 289-293 (2020)
PURPOSE: The purpose of this study was to compare intravitreal ziv-aflibercept (IVZ) monotherapy to intravitreal bevacizumab (IVB) monotherapy in patients with exudative age-related macular degeneration (eAMD). MATERIALS AND METHODS: Patients with tr
Externí odkaz:
https://doaj.org/article/89faf88e886b45a982a059191cec13bf
Autor:
Ahmad M. Mansour, Mohammed Ashraf, Khalil M. El Jawhari, Michel Farah, Ahmed Souka, Chintan Sarvaiya, Sumit Randhir Singh, Alay Banker, Jay Chhablani
Publikováno v:
International Journal of Retina and Vitreous, Vol 6, Iss 1, Pp 1-4 (2020)
Abstract Background To evaluate the safety and efficacy of intravitreal ziv-aflibercept (IVZ) in the management of vitreous hemorrhage (VH) in eyes with previously lasered proliferative diabetic retinopathy (PDR). Methods In a prospective multicenter
Externí odkaz:
https://doaj.org/article/a7ed3ee1b29e47fcb9dc678af62612c9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.